Reduction in ultraviolet B light–induced erythema by oxymetazoline and brimonidine is mediated by different α‐adrenoceptors
Sign Up to like & getrecommendations! Published in 2018 at "Experimental Dermatology"
DOI: 10.1111/exd.13557
Abstract: When applied topically, oxymetazoline and brimonidine reduce the persistent facial erythema of rosacea; this effect is mediated by cutaneous vasoconstriction induced by postsynaptic activation of α‐adrenoceptors. We investigated the α‐adrenergic pharmacology of oxymetazoline and brimonidine.… read more here.
Keywords: induced erythema; oxymetazoline brimonidine; pharmacology; ultraviolet light ... See more keywords